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Abstract 
Background: One of the common causes of sudden cardiac death (SCD) in young people is hypertrophic 
cardiomyopathy (HCM) and the primary prevention of SCD is with an implantable cardioverter 
defibrillators (ICD). Concerning the incidence of appropriate ICD therapy and the complications 
associated with ICD implantation and discharge, patients with implanted ICDs are closely monitored and 
interrogation reports are generated from clinical consultations.   
Methods: In this study, we compared the performance of structured device data and unstructured 
interrogation reports for extracting information of ICD therapy and heart rhythm. We sampled 687 reports 
with a gold standard generated through manual chart review. A rule-based natural language processing 
(NLP) system was developed using 480 reports and the information in the corresponding device data was 
aggregated for the task. We compared the performance of the NLP system with information aggregated 
from structured device data using the remaining 207 reports.  
Results: The rule-based NLP system achieved F-measure of 0.92 and 0.98 for ICD therapy and heart 
rhythm while the performance of aggregating device data was significantly lower with F-measure of 0.78 
and 0.45 respectively. Limitations of using only structured device data include no differentiation of real 
events from management events, data availability, and disparate perspectives of vendor and data 
granularity while using interrogation reports needs to overcome non-representative keyword/pattern and 
contextual errors.  
Conclusions: Extracting phenotyping information from data generated in real-world requires the 
incorporation of medical knowledge. It is essential to analyze, compare, and harmonize multiple data 
sources for real-world evidence generation.  
 
Introduction  
Hypertrophic cardiomyopathy (HCM) is the most prevalent inheritable myocardial disease, one of the 
common causes of sudden cardiac death (SCD) in young people1-3. Implantable cardioverter defibrillators 
(ICDs) are effective in termination of ventricular arrhythmias (ventricular fibrillation or ventricular 
tachycardia)4-6, by monitoring heart rhythms and delivering corrective therapies in forms of anti-
tachycardia pacing (ATP) and/or shock as needed. For decades, ICDs have been implanted for primary 
prevention in HCM patients who have high risk of SCD such as family history of SCD7 8. However, 
several studies have reported highly variable data concerning the incidence of appropriate ICD therapy 
and the complications associated with ICD implantation and discharge9,10. Given the lifesaving nature and 
the undesired risks associated with medical devices, patients with implanted ICDs are closely monitored 
with clinical consultations occurring whenever ICD therapy is applied.  
To assess patient outcomes and to ensure that patients get treatment that is right for them, analyzing 
device data together with data from electronic health records (EHRs) is necessary11. During normal course 
of operation, these devices generate structured data consisting of numerical data about the ICD therapy 
itself as well as data about the underlying heart rhythm that triggered therapy. These structured data are 
stored in the device’s own counters and then transmitted to the management system of the healthcare 
provider. After the occurrence of an interrogated event of ICD device such as an unscheduled visit, in-
office visit, emergency phone-call from a patient, or automated telephone alert by the device, an 
electrophysiologist or trained electrophysiology nurse reviews the electrograms in the time window 
surrounding the event on top of this structured data on the management system. The reviewer then creates 
an unstructured ICD interrogation report to interpret ICD therapy, heart rhythm data, past events, along 
with the device’s underlying programming information with the approval of healthcare providers. 
Integration or utilization of data from device into EHR has been investigated mainly to access real-word 
data for healthcare providers and to ensure the safety of patients who have ICD devices through data 
standardization and improvement of interoperability 11-14.  
Given the overall incidence of sudden death is relatively low among HCM patients, it is desired to predict 
patients with high risk of SCD who can benefit most from ICD implantation. One necessary step to 
develop predictive models is to accurately assess the adverse cardiac endpoints. In this situation, it would 
either be patients who died suddenly or patients with ICD devices who had an appropriate discharge for a 
ventricular arrhythmia. Towards the goal of accurately asserting cardiac endpoints, in this study, we 
analyzed and compared device data and interrogation reports for extracting phenotyping information of 
ICD therapy and heart rhythm for a cohort of HCM patients with ICD implanted.  
Materials 
MedTagger: An Information Extraction System 
MedTagger, a system capable of autonomously extracting clinical events from unstructured texts given a 
clinical dictionary and ruleset15, has been adapted here to extract electrophysiology experts’ interpretation 
of whether an appropriate ICD therapy was actually delivered as well as the identifiable heart rhythm at 
the event for comparative purposes with the structured data source. 
Patient Cohort 
For the purposes of this study, the patient cohort used for comparative purposes consisted initially of a 
cohort of 11,690 patients with a billing diagnosis of HCM (index date: Feb 15, 2019). This HCM cohort 
was then filtered using structured data from the electronic health record (EHR) of patients that explicitly 
were billed for implantation and/or occasional treatment or maintenance of an ICD, resulting in a cohort 
of 1,127 patients being used for this study with institutional review board approval. The specific 
structured data elements used for filtering purposes is defined in Table 1 below. 
Description Coding System Specific codes 
Patients with 
HCM  
ICD 9 (ICD-9-CM) 425.11, 425.18 
ICD 10 (ICD 10-CM) I42.2, I42.1 
AND 
ICD  
Diagnosis 
Codes 
ICD 9 (ICD-9-CM) 996.04, V45.02, V53.32 
ICD 10(ICD 10-CM) Z45.02, Z95.810 
OR 
ICD 
Procedural 
Codes 
Current Procedural 
Terminology (CPT) 
0319T, 0321T, 0326T, 33223, 33230, 33231, 
33240, 33241, 33243, 33244, 33249, 33262, 
33263, 33264, 33271, 33272, C1721, C1722, 
C1882 
Healthcare Common 
Procedure Coding System 
(HCPCS) 
C1777, C1895, C1896, C1899 
Table 1 - Cohort Criteria 
Methods 
Extraction of ICD Therapy and Heart Rhythm  
Datasets 
For the purposes of developing the MedTagger dictionary used for ICD therapy extraction, we subdivided 
687 randomly sampled ICD interrogation reports from the 1,127 patient cohort into a training and test set 
consisting of 70% being used for training (n=480 cases), and 30% for test (n=207 cases).  
Gold Standard for Training and Test 
The interpretations by electrophysiology experts in the interrogation reports within the dataset were 
annotated by three independent clinical abstractors. We defined the phenotypes as following: 
• ICD Therapy: When the device detects tachyarrhythmia, it delivers the programmed pacing 
stimulation (ATP therapy) and/or electrical shock (shock) to terminate arrhythmia. In this study, we 
consider an appropriate ICD therapy is if an interrogation report contains the effective ATP therapy 
and/or shock for tachyarrhythmia such as "Patient has had 2 VT episodes treated successfully with 
ATP X 1 each". In case of the failed ICD therapy or ICD therapy for irrelevant arrhythmia, we count 
as inappropriate ICD therapy. For example, "Patient received 3 failed ATP therapies, and EGMs 
reviewed and show AF." was inappropriate ICD therapies because of "failed therapies" and "atrial 
fibrillation". Our annotation task for ICD therapy is to determine whether appropriate ICD therapy is 
delivered or not.  
• Heart Rhythm: If an interrogation report contains any heart rhythm information (i.e. potential 
underlying reasons for ICD therapy such as “ventricular fibrillation”, “ventricular tachycardia”, 
“atrial fibrillation” and “atrial tachycardia”), then we consider it as valid heart rhythm. For example, 
if "EGMs show VT with rates 150 bpm that accelerated up to 220 bpm." was in an interrogation 
report; we defined valid heart rhythm identification due to the pattern "EGMs show VT". 
The procedure of annotation is as follows: two abstractors independently annotated each interrogation 
report to identify (1) appropriate ICD therapy and (2) identifiable heart rhythm. Any disagreement of 
annotations was adjudicated by the third abstractor, a board-certified cardiologist. The inter-annotator 
reliability of the annotation was calculated with percentage agreement and the Kappa statistic based on a 
randomly selected sample of 69 interrogation reports (10% of the total 687 interrogation reports).  
System Development 
From the gold standard annotations of the training set, patterns to extract ICD therapy as well as heart 
rhythm were identified and incorporated into the MedTagger ruleset. The resulting dictionary and the 
categorization of each pattern for a concept generated from this study are available for public use at 
https://github.com/RieaM/ICDNLP.git (website). The system extracts fine granularity concepts and 
normalizes them to the target phenotypes in our evaluation.  For example, “ATP therapy” and “shock” 
concepts were normalized into “ICD therapy”. Concepts related to heart rhythms, “ventricular 
fibrillation”, “ventricular tachycardia”, “atrial fibrillation” and “atrial tachycardia”, were all normalized 
into “heart rhythm”.  
System Evaluation 
The performance of the NLP pipeline and the performance based on information aggregated from 
structured device data were evaluated against the gold standard and the standard metrics used to evaluate 
information extraction pipelines, sensitivity, specificity, PPV, NPV, and F1-score were calculated and 
reported. 
Results 
For the inter-annotator reliability of our gold standard, the percent agreement was on 91% and the Kappa 
statistic was on 0.80 when extracting ICD therapy whereas 91% and 0.82 respectively when extracting the 
heart rhythm. The gold standard contained 290 appropriated ICD therapy cases (42% of 687) and 327 
heart rhythm cases (48% of 687).  
We obtained a reasonably high performance for the NLP pipeline to extract the interpreter’s assessment 
on whether ICD therapy was delivered with the corresponding heart rhythm information extracted. A 
comparison of the data pulled directly from the structured device data fields against their equivalents from 
the unstructured data from interrogation reports revealed the results as shown in Table 2. 
Data type Extraction 
Task 
Test Set Performance 
Sensitivity Specificity PPV NPV F-score 
Structured data ICD therapy 0.76 0.88 0.80 0.85 0.78 
Heart rhythm 0.33 0.87 0.70 0.58 0.45 
Unstructured data ICD therapy 0.99 0.90 0.86 0.99 0.92 
Heart rhythm 0.98 0.98 0.98 0.98 0.98 
Table 2 – Pipeline Performance using Structured or Unstructured Data for ICD Therapy and Heart Rhythm Extraction	
In Table 3, we categorized the major discrepancies (n=14 and n=4 for ICD therapy identification and 
Heart rhythm identification respectively in test set) the pipeline using unstructured data and the given 
gold standard.  
Error type Case Examples 
Inconsistent format  7 14J: Good detection, no dropped beats. (False Positive of ICD 
Therapy) 
Concept validity 3 The available EGM shows ventricular sensed beats at 52 bpm 
with a sudden rate increase to 120 - 136 bpm and a distinct 
morphology change which could indicate slow NSVT.  
(False Positive of Heart Rhythm) 
Non-representative pattern 5 Pt broke rhythm before shock delivered. (False Positive of ICD 
Therapy) 
Non-representative keyword 
(e.g. typo) 
2 Used 200 j externqal (typo of external) shock to convert 
rhythm to sinus. (False Negative of ICD Therapy) 
Negation 1 The transmission was reviewed, and showed no new VT/VF 
episodes. (False Positive of Heart Rhythm) 
Table 3 – Error Analysis 
	
Discussion, Challenges, and Future Direction 
In this study, we examined heterogeneous data available in the real-world healthcare system, structured 
data generated from ICD devices and unstructured data from ICD interrogation reports in EHR, to extract 
phenotyping information regarding ICD therapy and heart rhythm for HCM patients. Our system 
achieved 0.92 and 0.98 F-score for ICD therapy and heart rhythm identification respectively. 
Despite the reliable performance of our system, there are insurmountable challenges and error patterns 
associated with real-world data analysis of ICD device. The reasons behind the discrepancy between the 
system and the gold standard for this particular use case are many, and below we have presented several 
cases and how they relate to the three salient barriers presented in this study. 
Challenges of using structured data  
For the system using structured data only, we observed that there was a significant deterioration in 
performance both in terms of sensitivity and specificity compared to the system using unstructured data. 
These results suggest that these device-specific values are not necessarily reflective of the true underlying 
real-world values, at least within the clinical context pertaining to this particular dataset. 
A significant contributor to the lower specificity of device data lies in the fact that it could not distinguish 
between actual ICD therapy and adjustments of ICD devices due to medical needs. While standardizing 
structured information (record frequency in device counter in our case), a loss of granularity to adversely 
affect clinical information (indication of actual ICD therapy or adjustment of ICD device in our case) that 
may be useful16-18. For example, defibrillation threshold (DFT) testing which determines the threshold 
needed to terminate ventricular fibrillation at the time of device (re-)implantation is commonly practiced. 
Device functions are assessed to confirm appropriate settings during in-clinic visits on a regular basis. 
Intervention by physicians via the device (e.g. cardioversion) also frequently happened in emergency 
situations. Structured data generated through these device adjustments is recorded on the device counter 
in the same way as structured data generated by real events. (n=9)  
Another significant contributor to the lower specificity lies in the fact that the data is tied to the device 
itself, unavailable or missing information at the point of care: when the device was not accessible, 
switched, or reset, the historical data was cleared and no longer accessible, thus leading to missed events 
in the structured data. In particular, the majority of heart rhythms were adjudicated based on reviewing 
other available material (e.g. historical EGM,	transmission via device, downloaded evaluation on the 
management system of healthcare provider, etc.) and recorded as narrative in ICD interrogation reports. 
(n=65)  
The information extraction and generation strategies implemented out-of-the-box from device represent 
only a single semantic perspective of the information and are defined by the vendor. This may not always 
align semantically with the most current interpretations of the underlying unstructured data as used by 
healthcare providers 18,19. In this study, the low sensitivity lies in this fact that vendors hold differing 
definitions of how to define concepts (e.g. therapy or aborted therapy). While structured data contains 
valid information (frequency in device counter), the reviewer adjudicated as there was no valid therapy 
based on reviewing other material such as available electrogram (n=13 in ICD therapy identification, n=7 
in heart rhythm identification). It is important to note that our emphasis that structured device-generated 
data represents a single semantic perspective on the underlying data does not mean that it is an inaccurate 
perspective; indeed the structured data provided by the ICD devices in our case study here can be 
considered no more or no less valid than those provided by each of our expert interpreters depends on the 
medical needs. If the device discharged due to detecting an abnormal event but the heart rhythm resolved 
itself, therapy is diverted (e.g. “Pt broke rhythm before shock delivered.”). This, however, is recorded as a 
positive shock by the vendor, a semantic interpretation that did not agree with that of our human 
interpreters. The fact that such a difference of concept exists vindicates our assertion that multiple 
semantic perspectives do exist. 
An additional interesting finding is that the scope of information, i.e. the level of data granularity, defined 
by the device may not correspond to the needs of healthcare providers and depends on the circumstances 
20. Depending on the device, the fine level concepts of “ventricular fibrillation” and “ventricular 
tachycardia” could be combined as “ventricular rhythm” and “atrial fibrillation” and “atrial tachycardia” 
potentially represented as “atrial rhythm”. Although these fine level concepts may not be essential for the 
device to function efficiently, the fine granularity of heart rhythm can be useful for long-term medical 
needs. 
Challenges of using unstructured data 
With all that being said, we also cannot conclusively state that using unstructured data only is the correct 
approach to take either: an inherent difficulty in computational extraction of information from 
unstructured data is that it is not 100% accurate, with wide variances in terms of performance. Our system 
has common NLP challenges such as dealing with non-representative keyword/pattern (e.g. typo), the 
contextual errors in long sentences (e.g. negation or certainty), etc. In particular, our system had 
difficulties in recognizing the paragraph that contained device test information because of fragmented 
sentences or inconsistent formats in ICD interrogation reports (n=8 in ICD therapy identification). For 
example, the sentence “device charged for second shock” contained appropriate ICD therapy information 
from the sentence level perspective. However, the adjacent sentence contained the phrase “cardioversion 
via device” which provided a clue that this therapy was not a real event.  
Challenges of incorporating available heterogeneous datasets with the clinical needs 
In order to harness the heterogeneous dataset for medical purposes, we found it necessary to design with 
medical knowledge. If we simply combined structured (i.e. information aggregated) and unstructured data 
(i.e. information extracted using NLP) through Boolean logic OR, the overall performance dropped 
except for a slight improvement of sensitivity (Table 4).  
Extraction Task Test Set Performance 
Sensitivity Specificity PPV NPV F-score 
ICD therapy 1.00 0.79 0.75 1.00 0.86 
Heart rhythm 0.99 0.85 0.86 0.99 0.92 
Table 4 – Pipeline Performance using Structured and Unstructured Data without medical knowledge 
Deficiency in specificity is due to the format of the structured data, i.e., a data lake that makes no 
distinction between actual ICD therapy and adjustments of ICD devices. Improvement of sensitivity is 
evident from our analysis of information extracted. However, relying only on unstructured data will likely 
not be sufficient. For example, a report with sentences such as “patient was seen for recent arrhythmia 
with ICD shock” followed by “however, there was no therapy after investigation of device” contradicts 
the validity of the ICD therapy. Additionally, we found there are 2 cases with structured data providing 
therapy and heart rhyme information but such information failed to be captured in the interrogation 
reports. 
Limitations and Future Direction 
This study utilized the ICD interrogation reports to generate as the gold standard for reporting 
performance that may favorable to unstructured data. The information content supplied by the ICD device 
differs by vendors. But nevertheless, the conclusions drawn here remain generalizable as the key 
underlying reasons why such a deficiency exists will remain valid regardless of how that structured data is 
sourced. This variation in semantic perspectives of interest between diverse dataset from different 
resources is similar to the variation that exists in the real world. In order to make any clinical decision at 
the point of care, these semantic perspectives, structured and unstructured, must both be considered when 
developing and training any system underlying semantics and reasoning of medical needs. Regardless 
information extraction approaches relying purely on structured data will consistently face significant 
challenges; there is the value of structured data holds the consistency of method. Implication of our 
findings is that device data should always be paired with unstructured data for extracting phenotyping 
information.  
Conclusions 
We have analyzed device data from ICD together with EHR data for HCM patients with the ultimate goal 
of identifying patients who would benefit most from ICD therapy. Through the comparison of structured 
device data and unstructured interrogation reports for extracting phenotyping information of ICD therapy 
and heart rhythm, we demonstrated that relying on device data only does not reflect the underlying 
phenotyping information in the real-world clinical context. Meanwhile, the interrogation reports contain 
rich and complex information for a diverse range of purposes with different semi-structured formats, 
causing significant challenges in extracting phenotyping information. 
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